Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baseline Characteristics and Maintenance Therapy Choice on Symptom Control, Reliever Use, Exacerbation Risk in Moderate-Severe Asthma: A Clinical Modelling and Simulation Study.
Paggiaro P, Garcia G, Roche N, Verma M, Plank M, Oosterholt S, Duong JK, Majumdar A, Della Pasqua O. Paggiaro P, et al. Among authors: oosterholt s. Adv Ther. 2024 Nov;41(11):4065-4088. doi: 10.1007/s12325-024-02962-2. Epub 2024 Sep 6. Adv Ther. 2024. PMID: 39240503 Free PMC article.
Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials.
van Dijkman SC, Yorgancıoğlu A, Pavord I, Brusselle G, Pitrez PM, Oosterholt S, Fumali S, Majumdar A, Della Pasqua O. van Dijkman SC, et al. Among authors: oosterholt s. Adv Ther. 2024 Mar;41(3):1201-1225. doi: 10.1007/s12325-023-02774-w. Epub 2024 Feb 1. Adv Ther. 2024. PMID: 38296921 Free PMC article.
Modelling ASthma TrEatment Responses (MASTER): Effect of individual patient characteristics on the risk of exacerbation in moderate or severe asthma: A time-to-event analysis of randomized clinical trials.
Oosterholt S, Pavord ID, Brusselle G, Yorgancıoğlu A, Pitrez PM, Pg A, Teli C, Della Pasqua O. Oosterholt S, et al. Br J Clin Pharmacol. 2023 Nov;89(11):3273-3290. doi: 10.1111/bcp.15801. Epub 2023 Jul 6. Br J Clin Pharmacol. 2023. PMID: 37221636 Free article.
Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications.
Ingleby-Talecki L, van Dijkman SC, Oosterholt SP, Della Pasqua O, Winter C, Cunnington M, Rebar L, Forero-Schwanhaeuser S, Patel V, Cooper JA, Bahinski A, Chaudhary KW. Ingleby-Talecki L, et al. Among authors: oosterholt sp. Clin Transl Sci. 2022 Aug;15(8):1978-1989. doi: 10.1111/cts.13311. Epub 2022 May 31. Clin Transl Sci. 2022. PMID: 35579204 Free PMC article.
16 results